Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Low FAS/CD95 Expression by CTCL Correlates with Reduced Sensitivity to Apoptosis that Can Be Restored by FAS Upregulation
Jianqiang Wu, Minakshi Nihal, Jawed A. Siddiqui, et al.
Journal of Investigative Dermatology (2008) Vol. 129, Iss. 5, pp. 1165-1173
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)
Sarah I. Jawed, Patricia L. Myskowski, Steven Horwitz, et al.
Journal of the American Academy of Dermatology (2014) Vol. 70, Iss. 2, pp. 205.e1-205.e16
Closed Access | Times Cited: 353
Cutaneous T‐cell lymphoma: 2016 update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2015) Vol. 91, Iss. 1, pp. 151-165
Open Access | Times Cited: 139
Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?
Julia Scarisbrick, Y.H. Kim, Sean Whittaker, et al.
British Journal of Dermatology (2014) Vol. 170, Iss. 6, pp. 1226-1236
Closed Access | Times Cited: 138
Candidate driver genes involved in genome maintenance and DNA repair in Sézary syndrome
Wesley J. Woollard, Venu Pullabhatla, Anna Lorenc, et al.
Blood (2016) Vol. 127, Iss. 26, pp. 3387-3397
Open Access | Times Cited: 99
Bacterial Toxins Fuel Disease Progression in Cutaneous T-Cell Lymphoma
Andreas Willerslev-Olsen, Thorbjørn Krejsgaard, Lise M. Lindahl, et al.
Toxins (2013) Vol. 5, Iss. 8, pp. 1402-1421
Open Access | Times Cited: 84
Cutaneous T‐cell lymphoma: 2014 Update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2014) Vol. 89, Iss. 8, pp. 837-851
Open Access | Times Cited: 67
A phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasis
Alain H. Rook, Gary S. Wood, Madeleine Duvic, et al.
Journal of the American Academy of Dermatology (2010) Vol. 63, Iss. 6, pp. 984-990
Closed Access | Times Cited: 81
Reduction of Fas/CD95 Promoter Methylation, Upregulation of Fas Protein, and Enhancement of Sensitivity to Apoptosis in Cutaneous T-Cell Lymphoma
Jianqiang Wu, Gary S. Wood
Archives of Dermatology (2010) Vol. 147, Iss. 4, pp. 443-443
Closed Access | Times Cited: 78
Cutaneous T‐cell lymphoma: 2011 update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2011) Vol. 86, Iss. 11, pp. 928-948
Open Access | Times Cited: 71
Tumor microenvironment in mycosis fungoides and Sézary syndrome
Belén Rubio González, Jasmine Zain, Steven T. Rosen, et al.
Current Opinion in Oncology (2015) Vol. 28, Iss. 1, pp. 88-96
Closed Access | Times Cited: 58
Methotrexate and Pralatrexate
Gary S. Wood, Jianqiang Wu
Dermatologic Clinics (2015) Vol. 33, Iss. 4, pp. 747-755
Open Access | Times Cited: 52
The Janus Face of Death Receptor Signaling during Tumor Immunoediting
Eimear O’ Reilly, Andrea Tirincsi, Susan E. Logue, et al.
Frontiers in Immunology (2016) Vol. 7
Open Access | Times Cited: 49
Current Status of HDAC Inhibitors in Cutaneous T-cell Lymphoma
Adriana T. Lopez, Susan E. Bates, Larisa J. Geskin
American Journal of Clinical Dermatology (2018) Vol. 19, Iss. 6, pp. 805-819
Closed Access | Times Cited: 47
Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways
Kalyani Patil, Shilpa Kuttikrishnan, Abdul Quaiyoom Khan, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 382-399
Open Access | Times Cited: 40
Downregulation of Fas Gene Expression in Sézary Syndrome Is Associated with Promoter Hypermethylation
Christine L. Jones, E. Mary Wain, Chung-Ching Chu, et al.
Journal of Investigative Dermatology (2009) Vol. 130, Iss. 4, pp. 1116-1125
Open Access | Times Cited: 64
Deficiency of SATB1 expression in Sézary cells causes apoptosis resistance by regulating FasL/CD95L transcription
Yang Wang, Mingwan Su, Liang Zhou, et al.
Blood (2011) Vol. 117, Iss. 14, pp. 3826-3835
Open Access | Times Cited: 57
Lack of T-Cell Receptor–Induced Signaling Is Crucial for CD95 Ligand Up-regulation and Protects Cutaneous T-Cell Lymphoma Cells from Activation-Induced Cell Death
Claus‐Detlev Klemke, Dirk Brenner, Eva-Maria Weiβ, et al.
Cancer Research (2009) Vol. 69, Iss. 10, pp. 4175-4183
Open Access | Times Cited: 57
Apoptosis Induction by SAHA in Cutaneous T-Cell Lymphoma Cells Is Related to Downregulation of c-FLIP and Enhanced TRAIL Signaling
Nadya Al‐Yacoub, Lothar F. Fecker, Markus Möbs, et al.
Journal of Investigative Dermatology (2012) Vol. 132, Iss. 9, pp. 2263-2274
Open Access | Times Cited: 54
Lessons learned from gene expression profiling of cutaneous T-cell lymphoma
Brittany Dulmage, Larisa J. Geskin
British Journal of Dermatology (2013) Vol. 169, Iss. 6, pp. 1188-1197
Open Access | Times Cited: 51
Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets
Ieva Saulīte, Wolfram Hoetzenecker, Stephan Weidinger, et al.
BioMed Research International (2016) Vol. 2016, pp. 1-15
Open Access | Times Cited: 40
STAT3 knockdown by siRNA induces apoptosis in human cutaneous T-cell lymphoma line Hut78 via downregulation of Bcl-xL
Navin Kumar Verma, Anthony M. Davies, Aideen Long, et al.
Cellular & Molecular Biology Letters (2010) Vol. 15, Iss. 2
Open Access | Times Cited: 46
Programmed cell death‐10 enhances proliferation and protects malignant T cells from apoptosis
Britt Lauenborg, Katharina Kopp, Thorbjørn Krejsgaard, et al.
Apmis (2010) Vol. 118, Iss. 10, pp. 719-728
Open Access | Times Cited: 44
SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis
Minakshi Nihal, Nihal Ahmad, Gary S. Wood
Cell Cycle (2013) Vol. 13, Iss. 4, pp. 632-640
Open Access | Times Cited: 43
IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation
María Noé Garcia, Daniel Grasso, Belén López‐Millán, et al.
Journal of Clinical Investigation (2014) Vol. 124, Iss. 11, pp. 4709-4722
Open Access | Times Cited: 41
T-cell lymphomas, a challenging disease: types, treatments, and future
Helen Ma, Maher Abdul‐Hay
International Journal of Clinical Oncology (2016) Vol. 22, Iss. 1, pp. 18-51
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top